Study at a glance
How does active vitamin D change gene activity in cells?
Researchers studied how calcitriol, the active vitamin D hormone, changes gene activity. They used a human cell line derived from leukaemia cells. They compared cells lacking the vitamin D receptor with control cells that retained it. They also used computer analysis to investigate how the genes were regulated.
Did cells need a vitamin D receptor for the measured gene responses?
In control cells, 109 genes met the response test after four hours and 1,341 after twenty-four hours. No genes met the same test in cells lacking the receptor. This supports a requirement for the receptor in the gene responses detected under these conditions. It does not prove that every possible response was absent.
What did computer analysis suggest about slower vitamin D responses?
Some genes responding later were predicted to be directly influenced by the receptor. A slower response therefore did not necessarily mean an indirect effect. The analysis also suggested that other proteins help regulate later responses. Selected experiments supported parts of this network, but not every predicted connection.
Do these cell findings show benefits from vitamin D supplements?
The researchers supplied active hormone directly to laboratory cells. They did not test vitamin D supplements or health benefits in people. Results from this cell line cannot describe every tissue. The experiment also cannot exclude rapid effects outside the gene responses it measured.
Read the full article below ↓Canonical vitamin D signalling involves receptor-dependent gene regulation, but the route from receptor binding to a transcriptional response is not a simple on-off switch. This appraisal uses Warwick and colleagues’ cellular study to distinguish measured receptor dependence from predicted regulatory connections. For the companion account, see VDR/RXR Signalling and Gene Regulation: Study Summary.
The canonical pathway and the question tested
In the canonical model, active vitamin D binds the vitamin D receptor, which works with retinoid X receptor and other regulatory proteins to influence transcription. Response elements, accessible chromatin and the surrounding regulatory environment help determine which genes respond. This model connects Vitamin D Receptors with Vitamin D and Gene Expression, but a diagram of the pathway does not establish every connection experimentally.
Warwick and colleagues investigated two particular uncertainties. First, they asked how to distinguish genes directly regulated by VDR from genes responding through intervening transcription factors. Second, they tested whether any measured transcriptional response to calcitriol remained when VDR was removed. The study therefore examines receptor dependence and regulatory organisation. It is not a structural analysis of the VDR/RXR complex, an independent test of every RXR interaction, or a clinical supplementation trial.
Cells, exposure and timing
The work used THP-1 cells, a human monocytic leukaemia cell line. These cells provide a reproducible model for studying vitamin D-responsive transcription, but they are not freshly isolated monocytes from a representative patient population. Their lineage and culture history are part of the experimental setting. Findings in this system require further testing before being treated as a universal map of all human tissues.
The investigators supplied 100 nM calcitriol or an ethanol vehicle. Supplying active hormone bypasses precursor conversion, so this experiment does not determine whether the cells could generate the same exposure from circulating 25-hydroxyvitamin D. Vitamin D Activation explains why those interventions address different steps. The experimental concentration also cannot be converted into an oral vitamin D dose.
Existing datasets sampled responses after 2.5, 4 and 24 hours. The new receptor-knockout experiments examined 4 and 24 hours with four independent RNA-sequencing replicates. These windows allow comparison of earlier and later transcriptional responses, but leave the interval between them sparsely sampled. A gene first detected as responsive at 24 hours may have begun changing considerably earlier.
Three measurements describe different parts of regulation
RNA sequencing measures the abundance of transcripts. VDR chromatin immunoprecipitation followed by sequencing identifies genomic regions associated with the receptor under the assay conditions. FAIRE sequencing identifies relatively accessible chromatin. None is interchangeable with the others: receptor association does not automatically establish a transcriptional change, and accessible DNA is not necessarily occupied by VDR.
The investigators combined those measurements instead of classifying every early response as direct and every late response as indirect. A directly regulated gene can respond slowly because of chromatin access, cofactor recruitment, transcriptional dynamics or messenger-RNA stability. Conversely, timing alone cannot identify the exact protein responsible for a change. Integrating several assays makes the proposed regulatory relationship more informative while retaining the limits of each measurement.
How direct targets were predicted
Three computational approaches linked candidate regulatory regions with responsive genes. One assigned measured VDR-associated regions within 25 kilobases on either side of a transcription start site. Another used regulatory elements linked to genes in the EpiRegio database. The third searched accessible regions for predicted VDR-related binding motifs, again using a defined window around a gene’s start site.
These approaches supply different kinds of support. A measured association has a different evidential basis from a sequence motif predicted to bind a receptor. A regulatory element correlated with a gene across other datasets also introduces assumptions about whether that relationship operates in the experimental cell state. Agreement between approaches increases confidence, but does not turn a prediction into a selectively tested enhancer-to-gene connection.
The size of the genomic window creates a trade-off. A narrow window can miss a distant enhancer; a wider one can assign a receptor-associated region to the wrong gene. Likewise, absence of a recognised motif may reflect limitations of motif models or indirect association through another protein. The classification is therefore an explicit model of direct regulation, not a definitive catalogue of experimentally proven causal contacts.
Late responses can still have direct receptor involvement
The analysis assigned a substantial fraction of late-responsive genes to the predicted direct-target category. That finding challenges a simple time-based division of vitamin D action. A delayed response need not require an intervening newly produced transcription factor, just as an early response does not by itself reveal the responsible regulatory element.
The reported proportions vary with the prediction rule. Requiring support from more than one method reduces the number of genes classified as direct targets. The paper also reports some differing percentages across its results and discussion, so a single percentage should not be treated as a universal biological constant. The robust interpretive point is the dependence of classification on both evidence and analytical criteria.
This matters for Vitamin D Signalling Pathways: the canonical pathway can produce responses with different delays. A pathway map should distinguish the molecular route from the time when an assay first detects its output. Without that distinction, slow direct responses can be incorrectly assigned to a separate mechanism.
The receptor-knockout experiment
The investigators used CRISPR/Cas9 editing to generate VDR-deficient cells and compared them with cells carrying a non-targeting guide. Protein measurements assessed receptor loss in lines produced with several guide RNAs. The transcriptome experiment then used a selected knockout line and a selected control line. That distinction matters: validation across several guide designs does not mean that the entire transcriptomic experiment was independently repeated in every line.
The RNA-sequencing analysis used DESeq2 with an adjusted P-value cutoff of 0.05 and accounted for the cell batch. In the control cells, 109 genes met that differential-expression criterion after four hours and 1,341 after twenty-four hours. No gene met that criterion for a calcitriol response in the knockout cells. These findings support dependence of the detected transcriptional programme on VDR in this model. Comparisons of ligand-treated knockout and control cells, together with the response patterns of example genes, reinforced that interpretation.
The control-line response contained fewer detected genes than the earlier wild-type dataset used for prediction. The authors examined overlap between the datasets rather than assuming that they were identical. This is an important distinction when combining experiments: differences in preparation and analysis can affect how many genes cross a significance threshold without necessarily overturning the shared biological pattern.
What the knockout does and does not rule out
No statistically detected response is not the same as proof that every transcript changed by exactly zero. The conclusion depends on the sampled times, sequencing depth, replicate variation and differential-expression threshold. It is also restricted to the measured transcriptional outcome. A rapid change in an existing protein, ion flux or another non-transcriptional process could occur without being captured by this assay.
The result therefore does not abolish the possibility of rapid vitamin D signalling in other cells. It shows that the transcriptional response detected here required VDR. A rapid pathway could converge on VDR-dependent regulation, and another tissue could organise its responses differently. The appropriate comparison with a PDIA3 experiment is about model and endpoint, not a claim that one study automatically disproves the other.
Secondary responses form a regulatory network
Among the predicted primary targets, the authors identified 47 genes encoding transcription factors. Some responded earlier and others later. This creates a plausible route by which an initial VDR-dependent change could alter additional genes, as explained in Vitamin D and Transcription Factors. It also means that a gene can be influenced by both direct receptor-associated regulation and downstream factors rather than belonging to a perfectly isolated category.
The network analysis prioritised candidate regulators and predicted their connections with responsive genes. Such a network is useful for selecting experiments, but the appearance of an arrow in it is not equivalent to direct functional validation. Several regulators can be assigned to the same gene, and model coefficients describe an analytical contribution rather than a measured amount of biological control.
CEBPA and ETS1 provided targeted checks
The investigators examined CEBPA and ETS1 in more detail. Chromatin-association data supported selected predicted links, including association near secondary-response genes without corresponding strong VDR association. Those observations are consistent with an intervening regulatory layer. They do not establish that every predicted connection in the forty-seven-factor network operates with the same strength or mechanism.
A previously generated CEBPA-depletion dataset supplied a functional comparison. Of 1,256 vitamin D target genes predicted to bind CEBPA, 734 responded to calcitriol in control cells, depleted cells or both. Within that overlapping set, 124 lost their response after depletion, 162 gained a response and 448 retained one. Retention did not mean an unchanged response size: the supplementary heatmap of the fifty leading retained targets showed reduced induction for most of them. CEBPA therefore did not behave as a simple switch that only enables vitamin D action. It could shape basal expression and ligand responsiveness in different ways at different genes.
This distinction strengthens the interpretation of Vitamin D and Cell Differentiation. A lineage-associated regulatory environment can influence which responses are available. It does not mean that receptor abundance alone determines the entire programme or that the same network must occur in a muscle fibre, airway cell or skin keratinocyte.
Immune, metabolic and endocrine connections
Several identified regulators connect conceptually with immune or metabolic biology. That makes the network relevant to Vitamin D and Inflammatory Signalling and Vitamin D and Endocrine Crosstalk. Those links provide physiological context; the experiment did not measure an integrated clinical improvement across these systems.
Pathway enrichment asks whether a gene set contains more members of a named pathway than expected under a statistical model. It does not measure metabolic flux, immune protection or endocrine feedback directly. The paper’s regulator-specific enrichment findings should therefore remain gene-set observations. They cannot establish that a supplement improves a person’s metabolism or reduces systemic inflammation.
The distinction between a cultured monocytic cell and a circulating hormone system is particularly important. The culture lacks the complete interactions among endocrine organs, nutrient supply, tissue metabolism and immune-cell recruitment. Those omitted relationships are reasons for further experiments, not permission to fill the missing steps with presumed benefit.
Conclusion
The study supports VDR dependence of the measured calcitriol-induced transcriptional programme in THP-1 cells and shows why response timing alone is an inadequate guide to direct regulation. Its combined genomic analyses identify candidate direct targets and secondary regulatory networks, with selected experimental support. The evidence is strongest for this defined cellular response. It does not validate every predicted connection, exclude all rapid non-transcriptional mechanisms or establish a clinical benefit from vitamin D supplementation.
Sources and publication details
A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick Timothy and colleagues. Scientific Reports. 2021;11:6518. DOI: 10.1038/s41598-021-86032-5. PMID: 33753848. The source is licensed under Creative Commons Attribution 4.0. This article presents an original explanation and appraisal; source wording and figures have not been reproduced.
Related reading
1,25-Dihydroxyvitamin D Induces a NURR1-Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models
Tyrosine hydroxylase (TH) encodes a neuronally expressed enzyme that catalyzes the initial, rate-limiting step in the production of several catecholamine neurotransmitters and hormones, including dopamine, norepinephrine, and epinephrine.
Original paper ↗Read more →A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Original paper ↗Read more →A long non-coding RNA as a direct vitamin D target transcribed from the antisense strand of the human HSD17B2 locus
Vitamin D (VD) exerts a wide variety of actions via gene regulation mediated by the nuclear vitamin D receptor (VDR) under physiological and pathological settings.
Original paper ↗Read more →Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications
The key amino acids and structural requirements governing VDR binding to nuclear coactivators (NCoA) are well defined.
Original paper ↗Read more →Brain region-dependent gene networks associated with selective breeding for increased voluntary wheel-running behavior
The cerebellum and striatum from a high voluntary running line and a non-selected control line were compared.
Original paper ↗Read more →Comparing Gene Expression in the Parabrachial and Amygdala of Diestrus and Proestrus Female Rats after Orofacial Varicella Zoster Injection
The expression of genes in the parabrachial and amygdala in diestrus (low estradiol) and proestrus (high estradiol) female rats were evaluated in this study.
Original paper ↗Read more →Decreased Vitamin D Levels and Altered Placental Vitamin D Gene Expression at High Altitude: Role of Genetic Ancestry
There was a significant interaction of genetic ancestry with altitude in the ratio of 1α,25-(OH)2-D to 25-OH-D; with the ratio being significantly lower in Europeans compared to Andeans living at high altitude.
Original paper ↗Read more →Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation
Vitamin D receptor (VDR) is present in multiple blood cells, and the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D) is essential for the proper functioning of the immune system.
Original paper ↗Read more →Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis
The mineralized skeleton is a major evolutionary novelty that has contributed to the impressive morphological diversifications of the vertebrates.
Original paper ↗Read more →Functional analyses of a novel missense and other mutations of the vitamin D receptor in association with alopecia
The aim of this study is to elucidate the mechanism of functional disruption of a novel mutation, detected in a patient with HVDRR, comparing to other mutations with or without alopecia.
Original paper ↗Read more →Human retinal organoids release extracellular vesicles that regulate gene expression in target human retinal progenitor cells
The mechanisms underlying retinal development have not been completely elucidated.
Original paper ↗Read more →Interaction between allelic variations in vitamin D receptor and retinoid X receptor genes on metabolic traits
Low vitamin D status has been shown to be a risk factor for several metabolic traits such as obesity, diabetes and cardiovascular disease.
Original paper ↗Read more →Per: and Polyfluoroalkyl Substance-Induced Skin Barrier Disruption and the Potential Role of Calcitriol in Atopic Dermatitis
This study aimed to evaluate the effects of perfluorononanoic acid (PFNA) and perfluorooctanoic acid (PFOA), two widely detected PFASs, on epidermal function and gene expression in Human Epithelial Keratinocyte, neonatal (HEKn).
Original paper ↗Read more →PPAR-γ, RXR-α, and VDR Expression in Gingival Tissues of Patients with Grade B and Grade C Periodontitis: A Cross-Sectional Clinical Immunohistochemistry Study
Forty-five participants were allocated to three groups: Group 1, healthy controls; Group 2, stage 3 grade B periodontitis; and Group 3, stage 3 grade C periodontitis.
Original paper ↗Read more →The Immunomodulatory Activity of High Doses of Vitamin D in Critical Care Patients with Severe SARS-CoV-2 Pneumonia: A Randomized Controlled Trial
Methods: A nonblinded, randomized controlled trial was conducted.
Original paper ↗Read more →Viral infection of human neurons triggers strain-specific differences in host neuronal and viral transcriptomes
Infection with herpes simplex virus 1 (HSV-1) occurs in over half the global population, causing recurrent orofacial and/or genital lesions.
Original paper ↗Read more →Vitamin D enhances antiviral responses in dengue virus-infected macrophages by modulating early-response gene expression
Our temporal analysis revealed a progressive increase in cellular transcripts within the first hour of infection, with a more pronounced gene expression pattern in DENV-2-infected MDM compared to DENV-2-infected D3MDM at this early stage.
Original paper ↗Read more →Vitamin D-metabolic enzymes and related molecules: Expression at the maternal-conceptus interface and the role of vitamin D in endometrial gene expression in pigs
Vitamin D is a secosteroid hormone with many varied functions including regulation of blood calcium levels, cell proliferation, immunity, and reproduction in mammals.
Original paper ↗Read more →Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1
To ensure that MeTC7 inhibits VDR/PD-L1 without off-target effects, we examined competitive inhibition of VDR by MeTC7, utilizing ligand-dependent dimerization of VDR-RXR, RXR-RXR, and VDR-coactivators in a mammalian 2-hybrid (M2H) assay.
Original paper ↗Read more →Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Hence the current study aimed to investigate VDR, RXR and PPARγ in BRCA1 mut breast cancer and to test whether any of the three may be associated with clinico-pathological criteria including overall survival.
Original paper ↗Read more →Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles
The ability of VDR to bind the mutant VDRE in the DRB1 promoter was evaluated by EMSA.
Original paper ↗Read more →Original sources
A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Publication details
A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick Timothy and colleagues. Scientific Reports. 2021;11:6518. DOI: 10.1038/s41598-021-86032-5. PMID: 33753848. The source is licensed under Creative Commons Attribution 4.0. This article presents an original explanation and appraisal; source wording and figures have not been reproduced.